Case Study : Partnering with Patient Advocacy to Deliver Genetic Services and Accelerate Clinical Trial Recruitment
InformedDNA provides expert genetics services to foundations and patient advocacy organizations. We’ve successfully addressed the challenge that many foundations face in supporting patients through the genetic testing and screening process necessary to identify appropriate candidates for clinical trial eligibility. We also help patient foundations to effectively leverage their outreach capabilities to engage pharmaceutical companies while […]
Achieving Value through Comprehensive Genomic Benefits Management
Genomics-informed precision health holds enormous promise for patients – and can impact every aspect of a health plan’s business. When properly integrated, precision health may enable tailored care and potentially improve outcomes. However, rapid advances – including a growing number of expensive genomic tests and treatments – far outpace the resources that most health plans […]
Coverage Decision Framework
Rapid advances in genomic science and the implementation of personalized medicine require new approaches to health plan policy and evidence review processes. InformedDNA genetics experts have developed a forward-thinking approach with its health plan Coverage Decision Framework™, enabling health plans to develop timely policies that ensure members have access to the most current, effective and […]
High-Touch Approach Streamlines Patient Identification Process in Clinical Trial
Our client, a leading biotech innovator committed to developing revolutionary personalized therapies for dementia and Alzheimer’s disease patients, relies heavily on positive outcomes from its clinical trials. Yet, identifying appropriate patients with the right gene mutation for these trials can be a challenge. When trial sites failed to identify enough patients for a phase 3 […]
Case Study : Expanding Access to Genetic Counseling Expertise
In 2012, a leading not-for-profit, community-based health system turned to InformedDNA to provide genetic counseling services as part of its genetics program for their patients. They continue to use these services today. The primary challenges that we address for our client include: Meeting current Commission on Cancer (CoC) and NAPBC standards regarding genetic counseling and […]
Case Study: Genetics Experts Support a Rare Disease Drug Pipeline
Until recently, many patients with rare disorders faced few to no treatment options. Gene-based therapies are beginning to change this reality. However, lack of physician awareness, limited access to genetic testing, and delays in diagnosis prevent many eligible patients from receiving these life-changing therapies. Through a partnership with a leading biotech company, InformedDNA provided patient […]
FAQ Videos: Genetic Test Payment Integrity for Health Plans
Inappropriate genetic testing spend is a big concern for health plans. Our expert genetic analysts understand this pain point and have some answers to commonly posed questions by health plans. Take a few minutes to watch our two-part video series in which one of our genetics claims analysts and board-certified genetic counselor, Katie Wiens, answers […]
Choosing a Genetic Testing Lab: Six Essential Questions for Healthcare Providers
The National Institutes of Health warns that “most genetic tests today are not regulated, meaning that they go to market without any independent analysis to verify the claims of the seller.”
Solving Patient Identification and Recruitment Challenges With Clinical Genetics Expertise
A disease is considered rare when it affects fewer than 200,000 people. It’s estimated there are nearly 8,000 total rare diseases affecting more than 25 million people in the U.S. alone. Some of these diseases have even rarer genetic subtypes or variants. This makes it extremely difficult to identify and recruit patients for clinical research, […]
The In’s and Out’s of Genetic Testing Payment Integrity
In part one of this blog series, we answered common questions posed by medical directors and claims management leaders at health plans. Because accurately reviewing and identifying genetic testing claims payments can be incredibly complex, we continue the conversation with our experts in this blog and turn our focus to the logistics of the payment […]
